CN102660645A - Primer and probe combination and kit for specifically detecting streptococcus pneumoniae and haemophilus influenzae - Google Patents

Primer and probe combination and kit for specifically detecting streptococcus pneumoniae and haemophilus influenzae Download PDF

Info

Publication number
CN102660645A
CN102660645A CN2012101370670A CN201210137067A CN102660645A CN 102660645 A CN102660645 A CN 102660645A CN 2012101370670 A CN2012101370670 A CN 2012101370670A CN 201210137067 A CN201210137067 A CN 201210137067A CN 102660645 A CN102660645 A CN 102660645A
Authority
CN
China
Prior art keywords
streptococcus pneumoniae
primer
test kit
nucleic acid
hemophilus influenzae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012101370670A
Other languages
Chinese (zh)
Other versions
CN102660645B (en
Inventor
文锋
其他发明人请求不公开姓名
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZHENJIANG HECHUANG BIOTECHNOLOGY CO Ltd
Original Assignee
ZHENJIANG HECHUANG BIOTECHNOLOGY CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZHENJIANG HECHUANG BIOTECHNOLOGY CO Ltd filed Critical ZHENJIANG HECHUANG BIOTECHNOLOGY CO Ltd
Priority to CN201210137067.0A priority Critical patent/CN102660645B/en
Publication of CN102660645A publication Critical patent/CN102660645A/en
Application granted granted Critical
Publication of CN102660645B publication Critical patent/CN102660645B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to an oligonucleotide sequence combination for specifically detecting existence of streptococcus pneumoniae and haemophilus influenzae nucleic acids in samples by adopting fluorescent PCR (polymerase chain reaction) technology and a kit comprising the combination. The kit can sensitively detect and identify the streptococcus pneumoniae and haemophilus influenzae nucleic acids in the samples, has limits of detection of 20 copies per reaction system and has important application values in the fields such as disease surveillance and clinical diagnosis.

Description

The specific detection of streptococcus pneumoniae and hemophilus influenzae is with primer probe combinations and test kit
Technical field
The present invention relates to a kind of employing fluorescent PCR technology, the oligonucleotide sequence combination that streptococcus pneumoniae and hemophilus influenzae nucleic acid exist in the specific detection sample, and the test kit that comprises this combination.
Technical background
The pathogenic agent of bacterial pneumonia has than big-difference because of host's age, accompanying diseases and immune functional state.With regard to the acquisition mode, common in the community acquired pneumonia pathogenic agent is streptococcus pneumoniae and hemophilus influenzae.
Streptococcus pneumoniae is a GPC, is the main pathogenic agent that causes bacterial pneumonia, account for its about 2/3, all can fall ill the whole year, winter-spring season is occurred frequently.Hemophilus influenzae is the gram-negative dialister bacterium, and is occurred frequently in the children at 4-18 monthly age, can cause bacterial pneumonia and bacterial meningitis.According to the WTO statistic data, there are every year 300000 people of surpassing to die from pneumonia and the meningitis that hemophilus influenzae causes.The laboratory diagnosis of streptococcus pneumoniae mainly relies on pathogenic bacteria to cultivate.Traditional detection method needs culture of isolated to go out could to identify after the bacterial strain, need the time longer.And the hemophilus influenzae growth conditions is harsh, and nutritional requirement is very high, wastes time and energy, and is unfavorable for rapid detection, and for operator, possesses certain danger.PCR reaction Fast Detection Technique to pathogenic agent begins to occur in recent years.Detect for PCR, selection of primers is most important, directly the specificity of influence detection.If primer specificity is not enough, the false positive results that then possibly cause detecting or the appearance of false negative result.
Detection for streptococcus pneumoniae and hemophilus influenzae in the pneumonia patient respiratory road secretory product is an important step of finding out the cause of disease, selects significant for clinical diagnosis and medicine.
The present invention is directed to streptococcus pneumoniae and hemophilus influenzae special target sequence design primer and Taqman probe; Utilize the method for real-time PCR; Be used for differentiating streptococcus pneumoniae and hemophilus influenzae nucleic acid in the test sample, can obtain the specific detection result fast.
Summary of the invention
For test sample streptococcus pneumoniae and hemophilus influenzae nucleic acid exist more exactly; The present invention provides the oligonucleotide sequence combination of streptococcus pneumoniae and hemophilus influenzae in a kind of specific detection sample and comprises the test kit of this combination, it is characterized in that the primer that is used for nucleic acid amplification in the PCR reaction solution of combined sequence or test kit is:
P1:5`-AGTCGTTCCAAGGTAACAAGT-3`,
P2:5`-CACGCACCGACTACCTAAACC-3`,
P3:5`-TGCAACTCCAGCTGCTAAAGTATT-3`,
P4:5`-TCTTCACCGTAAGATACTGTGCC-3`。
P1 and P2 Auele Specific Primer for being directed against streptococcus pneumoniae genome specificity sequences Design and filtering out through preliminary experiment, P3 and P4 Auele Specific Primer for being directed against hemophilus influenzae genome specificity sequences Design and filtering out through preliminary experiment.
Characteristic of the present invention is that also the oligonucleotide probe that is used for the fluorescent signal monitoring in the PCR reaction solution of combined sequence or test kit is:
Probe1:5`-X 1-GATCAGATTGAAGCTGATAAAACGATACA-Y 1-3`,
Probe2:5`-X 2-TAGGTCAACGTCGTGCAGATGCAGTT-Y 2-3`。
X 1And X 2Be fluorescence report group, Y 1And Y 2Be the fluorescent quenching group.The specific probe of Probe1 for being directed against streptococcus pneumoniae genome specificity sequences Design and filtering out through preliminary experiment, the specific probe of Probe2 for being directed against hemophilus influenzae genome specificity sequences Design and filtering out through preliminary experiment.
Characteristic of the present invention is that also test kit comprises PCR reaction solution, enzyme mixed solution, negative quality control product and positive quality control product.Wherein the PCR reaction solution mainly contains above-mentioned primer and probe, reaction buffer, Mg 2+With dNTP etc., the enzyme mixed solution mainly contains warm start Taq enzyme, and negative quality control product is a deionized water, and positive quality control product is to contain the nucleic acid that detects target sequence.
Another preferred embodiment of the present invention is: be used for the fluorophor branch of the oligonucleotide probe of fluorescent signal monitoring in the PCR reaction solution of combined sequence or test kit, wherein Probe1 fluorescence report radicals X 1Be Fam, fluorescent quenching group Y 1Be Eclipse, Probe2 fluorescence report radicals X 2Be Hex, fluorescent quenching group Y 2Be Eclipse.
Another preferred embodiment of the present invention is: test kit comprise above-mentioned two pairs of Auele Specific Primers and two specific probes; Belong to the real-time fluorescence double PCR and detect, can be in same reaction system streptococcus pneumoniae and hemophilus influenzae nucleic acid are detected and differentiates.
Another preferred embodiment of the present invention is: the PCR reaction cycle parameter of test kit is 95 ℃, 2min; Get into the cycle stage: 95 ℃ of sex change 10s, 1min, 40 circulations of coreaction are extended in 60 ℃ of annealing.
Another preferred embodiment of the present invention; The PCR reaction system that test kit is selected for use is 20 μ l; Comprise 2 * PCR damping fluid, 10 μ l, 10mmol/L dNTP 1.0 μ l, each 0.5 μ l of 25 μ mol/L primers, each 0.2 μ l of 10 μ mol/L probes, warm start Taq enzyme mixed solution 0.2 μ l, sample DNA 2 μ l, adding aqua sterilisa to end-body is 20 μ l.
Be limited to 20 every reaction systems of copy under the detection of test kit provided by the invention to streptococcus pneumoniae nucleic acid; Be limited to 20 every reaction systems of copy under the detection to hemophilus influenzae nucleic acid.
The present invention is respectively according to streptococcus pneumoniae or hemophilus influenzae genome conserved regions difference design specific primers and probe; The test kit that provides can detect the nucleic acid of streptococcus pneumoniae or hemophilus influenzae; But can not detect the nucleic acid of non-streptococcus pneumoniae or hemophilus influenzae pathogenic agent, explain that test kit has excellent specificity.
Test kit provided by the invention can be accomplished detection in 3 hours, and double check can be saved 50% testing cost, and the disease surveillance and the clinical diagnosis that can be streptococcus pneumoniae or hemophilus influenzae provide experimental basis.
Description of drawings
Fig. 1 detects the amplification curve diagram of streptococcus pneumoniae nucleic acid sensitivity for dual real-time fluorescence PCR.5 curves from left to right are respectively streptococcus pneumoniae specific PCR fragment and make up plasmid gradient dilution (10 5-10 1) the back amplification.X-coordinate is the reaction cycle number, and ordinate zou is the Δ Rn value of different cycle number fluoroscopic examination signals.
Fig. 2 detects the amplification curve diagram of hemophilus influenzae nucleic acid sensitivity for dual real-time fluorescence PCR.5 curves from left to right are respectively hemophilus influenzae specific PCR fragment and make up plasmid gradient dilution (10 5-10 1) the back amplification.X-coordinate is the reaction cycle number, and ordinate zou is the Δ Rn value of different cycle number fluoroscopic examination signals.
Fig. 3 is that real-time fluorescence double PCR detection architecture is to streptococcus pneumoniae and hemophilus influenzae detection of nucleic acids specific amplification graphic representation.S type amplification curve all appears in streptococcus pneumoniae and hemophilus influenzae, and S type amplification curve does not all appear in other pathogenic micro-organism Quality Control bacterium.X-coordinate is the reaction cycle number, and ordinate zou is the Δ Rn value of different cycle number fluoroscopic examination signals.
Embodiment
Specify preferred implementation of the present invention below in conjunction with specific embodiment.It is pointed out that the embodiment that lists only is the purpose of exemplary illustration here, and should it be interpreted as any restriction to the scope of the invention.Reagent such as use therein test kit, damping fluid only are the concrete reagent of selecting in this specific embodiment, should be understood that corresponding reagent that those skilled in the art can select other companies as required is to realize the object of the invention.
1, the design of primer and TaqMan probe is with synthetic
Utilize the Blast instrument that all streptococcus pneumoniaes in Genbank and the domestic and foreign literature and hemophilus influenzae genome sequence are analyzed; Select its stable conservative region as the detection target sequence respectively, and be directed against design of these two detection target sequences and synthetic primers and the probes (seeing table 1) of overlapping more.Primer and probe are synthetic by the precious biotech firm in Japanese TaKaRa Dalian; Wherein the detection probes 5 ' of streptococcus pneumoniae is held flag F AM fluorophor; 3 ' end mark Eclipse fluorescent quenching group; Detection probes 5 ' the end mark Hex fluorophor of hemophilus influenzae, 3 ' end mark Eclipse fluorescent quenching group.
2, detect the preparation of bacterial classification
Employed streptococcus pneumoniae, hemophilus influenzae and other negative control bacterial strains in the present embodiment (Bordetella pertussis, Bordetella parapertussis, A group meningitis Neisseria, B group meningitis Neisseria, C group meningitis Neisseria, mycoplasma pneumoniae, legionella pneumophilia, CPN and moraxelle catarrhalis) are all bought in Nat'l Pharmaceutical & Biological Products Control Institute.
3, the extracting of bacterial strain DNA
Select the QIAamp DNA Mini Kit of Qiagen company (article No.: 51306) extract bacterial strain DNA for use.The concrete steps test kit is with reference to process specifications.
4, the screening of primer and probe
Many covers primer of employing design and probe be the genomic dna of streptococcus pneumoniae, hemophilus influenzae and the negative control bacterial strain bacterium of Detection and Extraction respectively, through experiment repeatedly, filters out sensitivity, specificity and repeated best primer probe combinations.(see sequence table, streptococcus pneumoniae forward primer p1, reverse primer p2 and probe probe1; Hemophilus influenzae forward primer p3, reverse primer p4 and probe probe2)
5, the structure of standard substance and preparation
Utilize p1, p2 and p3, p4 primer respectively; Pcr amplification streptococcus pneumoniae and hemophilus influenzae specific gene fragment; The PCR product cloning to the pMD-18T carrier, is transformed DH5 α intestinal bacteria, utilize alkaline lysis method of extracting positive colony plasmid; Utilize ultraviolet-visible pectrophotometer to be determined at the light absorption ratio of wavelength 260nm place, the DNA of 280nm place respectively, calculate plasmid concentration and purity then.10 times of gradient dilutions to 10 every microlitre of copy then.
6, reaction condition optimization
Key elements such as primer, probe, enzyme are optimized one by one; The reaction system of confirming is: 2 * PCR damping fluid, 10 μ l, 10mmol/L dNTP 1.0 μ l, each 0.5 μ l of 25 μ mol/L primers, each 0.2 μ l of 10 μ mol/L probes, warm start Taq enzyme 0.2 μ l, template 2ul, adding aqua sterilisa to end-body is 20 μ l.
According to amplified fragments length, primer and the annealing temperature of probe and the characteristic of enzyme, mainly reaction annealing temperature and extension time to be optimized, the final loop parameter of confirming is: sex change is 95 ℃ in advance, 2min; Amplification and detection: 95 ℃ of sex change 10s, 1min are extended in 60 ℃ of annealing, 40 circulations, each circulates in annealing and extends the phase acquisition fluorescent signal.
Finish the back by the identical conditions analytical data in amplification, confirm the Ct value of each sample.
7, the evaluation of detectability
Estimate the detectability of the test kit that provides of the present invention with the positive criteria article in above-mentioned 5, positive criteria article concentration is: 1 * 10 5Copies/ μ l, 1 * 10 4Copies/ μ l, 1 * 10 3Copies/ μ l, 1 * 10 2Copies/ μ l, 1 * 10 5Copies/ μ l, 1 * 10 5Copies/ μ l is limited to 20 every reaction systems of copy under the detection of test kit provided by the invention to streptococcus pneumoniae nucleic acid; Detection lower limit to hemophilus influenzae nucleic acid is 20 every reaction systems of copy.
8, the evaluation of detection specificity
Bacterial strain DNA with in above-mentioned 2 is the specificity that template has been estimated this test kit.All visible clear and definite amplification curve when streptococcus pneumoniae and hemophilus influenzae DNA are detected; When above-mentioned 9 kinds of other pharyngeal encountered pathogenic microbial DNAs are detected; Do not produce positive amplification curve, explain between probe that we use and primer and other bacterial strains that we select not have cross reaction.
Although in the preceding text with preferred mode; Through the specific embodiment exemplary illustration some embodiment of the present invention; But it will be understood by a person skilled in the art that; The present invention is not limited to top disclosed embodiment, but the knowledge of technical field is made amendment to it under can be according to the present invention, make an amendment and can not exceed the scope of requirement protection of the present invention.For example; Fluorescent real time PCR used in the present invention also can adopt fluorophor and the fluorescent quenching group mark substance of pointing out among the embodiment listed in the specification sheets in addition as required, like affinity tags such as Tet, FAM, HEX, TAMRA, ROX, Cy3, TxRd, JOE; Or other mark systems outside the use Taqman technology, for example fluorescent probe labeling techniques such as MGB probe, molecular beacon MB probe, scorpion shape probe, fluorescence double cross probe; Or use saturable dyes such as unsaturated dyestuff such as chimeric method of dyestuff such as SYBR Green I and LC Green; As long as it has used specific primer sequence of the present invention; Get final product the existence of qualitative or detection by quantitative goal gene, and then detect the existence of streptococcus pneumoniae and hemophilus influenzae specifically.So the change that these those skilled in the art understood and the replacement of customary means also fall in protection scope of the present invention.Protection scope of the present invention should be limited appending claims.
Figure ISA00000712021300011
Figure ISA00000712021300021

Claims (9)

1. combination of primers that is used for specific detection sample streptococcus pneumoniae and hemophilus influenzae nucleic acid, this cover combined sequence is characterised in that and comprises following primer:
P1:5`-AGTCGTTCCAAGGTAACAAGT-3`,
P2:5`-CACGCACCGACTACCTAAACC-3`,
P3:5`-TGCAACTCCAGCTGCTAAAGTATT-3`,
P4:5`-TCTTCACCGTAAGATACTGTGCC-3`。
2. a primer and oligonucleotide probe combination that is used for specific detection sample streptococcus pneumoniae and hemophilus influenzae nucleic acid, wherein primer is the described primer of claim 1, oligonucleotide probe is:
Probe1:5`-X 1-GATCAGATTGAAGCTGATAAAACGATACA-Y 1-3`,
Probe2:5`-X 2-TAGGTCAACGTCGTGCAGATGCAGTT-Y 2-3`。
X 1And X 2Be fluorescence report group, Y 1And Y 2Be the fluorescent quenching group.
3. of claim 2, this cover combined sequence characteristic also is, wherein Probe1 fluorescence report radicals X 1Be Fam, fluorescent quenching group Y 1Be Eclipse, Probe2 fluorescence report radicals X 2Be Hex, fluorescent quenching group Y 2Be Eclipse.
4. of claim 2, this cover combined sequence characteristic is that also can be used for the dual real-time fluorescence polymerase chain reaction and detect, promptly a reaction system can detect and differentiate streptococcus pneumoniae and hemophilus influenzae nucleic acid simultaneously.
5. test kit that is used for specific detection sample streptococcus pneumoniae and hemophilus influenzae nucleic acid is comprising PCR reaction solution, enzyme mixed solution, negative quality control product and positive quality control product.The primer sequence that it is characterized in that being used in the PCR reaction solution nucleic acid amplification reaction is following:
P1:5`-AGTCGTTCCAAGGTAACAAGT-3`,
P2:5`-CACGCACCGACTACCTAAACC-3`,
P3:5`-TGCAACTCCAGCTGCTAAAGTATT-3`,
P4:5`-TCTTCACCGTAAGATACTGTGCC-3`。
6. test kit as claimed in claim 5, the sequence of oligonucleotide probe that it is characterized in that being used in the PCR reaction solution fluorescent signal monitoring is following:
Probe1:5`-X 1-GATCAGATTGAAGCTGATAAAACGATACA-Y 1-3`,
Probe2:5`-X 2-TAGGTCAACGTCGTGCAGATGCAGTT-Y 2-3`。
X 1And X 2Be fluorescence report group, Y 1And Y 2Be the fluorescent quenching group.
7. test kit as claimed in claim 5, its characteristic also are to be used in the PCR reaction solution oligonucleotide probe of fluorescent signal monitoring: Probe1 fluorescence report radicals X wherein 1Be Fam, fluorescent quenching group Y 1Be Eclipse, Probe2 fluorescence report radicals X 2Be Hex, fluorescent quenching group Y 2Be Eclipse.
8. test kit as claimed in claim 5; Its characteristic is that also the PCR reaction system is 20 μ l; Comprise 2 * PCR damping fluid, 10 μ l, 10mmol/L dNTP 1.0 μ l, each 0.5 μ l of 25 μ mol/L primers, each 0.2 μ l of 10 μ mol/L probes, warm start Taq enzyme mixed solution 0.2 μ l, sample DNA 2 μ l, adding aqua sterilisa to end-body is 20 μ l.
9. test kit as claimed in claim 5, its characteristic are that also PCR reaction cycle parameter is:
94 ℃, 2min; Get into the cycle stage: 94 ℃ of sex change 10s, 1min, 40 circulations of coreaction are extended in 60 ℃ of annealing.
CN201210137067.0A 2012-05-07 2012-05-07 The specific detection of streptococcus pneumoniae and hemophilus influenza primed probe combination and test kit Active CN102660645B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210137067.0A CN102660645B (en) 2012-05-07 2012-05-07 The specific detection of streptococcus pneumoniae and hemophilus influenza primed probe combination and test kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210137067.0A CN102660645B (en) 2012-05-07 2012-05-07 The specific detection of streptococcus pneumoniae and hemophilus influenza primed probe combination and test kit

Publications (2)

Publication Number Publication Date
CN102660645A true CN102660645A (en) 2012-09-12
CN102660645B CN102660645B (en) 2016-09-28

Family

ID=46770220

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210137067.0A Active CN102660645B (en) 2012-05-07 2012-05-07 The specific detection of streptococcus pneumoniae and hemophilus influenza primed probe combination and test kit

Country Status (1)

Country Link
CN (1) CN102660645B (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102888460A (en) * 2012-10-12 2013-01-23 江苏大学 Multi-landing PCR kit and detection method of streptococcus pneumonia
CN105063218A (en) * 2015-08-20 2015-11-18 杭州市第一人民医院 Multiple quantitative PCR (polymerase chain reaction) kit for quick combined detection of four bacteria difficult to cultivate and identify
CN108559790A (en) * 2018-04-17 2018-09-21 南京岚煜生物科技有限公司 The kit and its application method of three kinds of respiratory pathogens are detected based on micro-fluidic chip
WO2019161469A1 (en) * 2018-02-20 2019-08-29 Fundação Oswaldo Cruz Oligonucleotide, set of oligonucleotides, method for simultaneous detection of neisseria meningitidis, streptococcus pneumoniae and haemophilus influenzae, and kit
CN110904253A (en) * 2019-12-18 2020-03-24 上海伯杰医疗科技有限公司 Encephalitis meningitis nucleic acid typing detection kit and detection method
CN112695110A (en) * 2020-12-29 2021-04-23 复旦大学 Primer group and kit for rapidly detecting streptococcus pneumoniae nucleic acid through polymerase helix reaction and application of primer group and kit
CN114790489A (en) * 2021-11-04 2022-07-26 江汉大学 MNP (MNP) marker site of haemophilus influenzae, primer composition, kit and application of MNP marker site

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1414112A (en) * 2002-08-30 2003-04-30 南开大学 Gene chip used for identifying pathogenic bacteria in blood and its making method
CN102409103A (en) * 2011-12-07 2012-04-11 江苏大学 Multiple landing PCR(Polymerase Chain Reaction) detection kit and detection method for pathogenic bacteria of lower respiratory tract

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1414112A (en) * 2002-08-30 2003-04-30 南开大学 Gene chip used for identifying pathogenic bacteria in blood and its making method
CN102409103A (en) * 2011-12-07 2012-04-11 江苏大学 Multiple landing PCR(Polymerase Chain Reaction) detection kit and detection method for pathogenic bacteria of lower respiratory tract

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102888460A (en) * 2012-10-12 2013-01-23 江苏大学 Multi-landing PCR kit and detection method of streptococcus pneumonia
CN102888460B (en) * 2012-10-12 2013-10-23 江苏大学 Multi-landing PCR kit and detection method of streptococcus pneumonia
CN105063218A (en) * 2015-08-20 2015-11-18 杭州市第一人民医院 Multiple quantitative PCR (polymerase chain reaction) kit for quick combined detection of four bacteria difficult to cultivate and identify
CN105063218B (en) * 2015-08-20 2018-06-29 杭州市第一人民医院 The multiple quantitative PCR reagent kit of the difficult culture identification bacterium of four kinds of fast joint inspection
WO2019161469A1 (en) * 2018-02-20 2019-08-29 Fundação Oswaldo Cruz Oligonucleotide, set of oligonucleotides, method for simultaneous detection of neisseria meningitidis, streptococcus pneumoniae and haemophilus influenzae, and kit
CN108559790A (en) * 2018-04-17 2018-09-21 南京岚煜生物科技有限公司 The kit and its application method of three kinds of respiratory pathogens are detected based on micro-fluidic chip
CN108559790B (en) * 2018-04-17 2021-04-13 南京岚煜生物科技有限公司 Kit for detecting three respiratory pathogens based on microfluidic chip and use method thereof
CN110904253A (en) * 2019-12-18 2020-03-24 上海伯杰医疗科技有限公司 Encephalitis meningitis nucleic acid typing detection kit and detection method
CN112695110A (en) * 2020-12-29 2021-04-23 复旦大学 Primer group and kit for rapidly detecting streptococcus pneumoniae nucleic acid through polymerase helix reaction and application of primer group and kit
CN114790489A (en) * 2021-11-04 2022-07-26 江汉大学 MNP (MNP) marker site of haemophilus influenzae, primer composition, kit and application of MNP marker site
CN114790489B (en) * 2021-11-04 2023-06-20 江汉大学 MNP (MNP) marking site of haemophilus influenzae, primer composition, kit and application of MNP marking site

Also Published As

Publication number Publication date
CN102660645B (en) 2016-09-28

Similar Documents

Publication Publication Date Title
CN102660645A (en) Primer and probe combination and kit for specifically detecting streptococcus pneumoniae and haemophilus influenzae
CN103642936B (en) The specific detection of 55 type adenoviruss primed probe combination and test kit
Lee et al. Evaluation of reverse transcription loop-mediated isothermal amplification in conjunction with ELISA–hybridization assay for molecular detection of Mycobacterium tuberculosis
KR20070105980A (en) Method of quantitatively analyzing microorganism targeting rrna
CN110951898B (en) New specific molecular target of 4 species in Cronobacter and rapid detection method thereof
CN102634596A (en) Bordetella pertussis and primer probe combination and kit for specific detection of bordetella parapertussis
CN102286612A (en) Fast detection reagent kit for pathogenic microorganism
CN103484532A (en) Composition and kit for detection and analysis of strains of clostridium difficile and method of detecting strains of clostridium difficile by using the same
CN102154278B (en) Rapid detection method for Tilletia controversa Kuhn and specific SCAR (sequence characterized amplified region) marker thereof
CN105567802A (en) Fluorescence PCR (polymerase chain reaction) detection kit for Chlamydia pneumoniae
CN1724686B (en) Target sequence used for detecting mycoplasma pnoumoniae and reagent box
CN102643920B (en) The specific detection of Neisseria meningitidis and discriminating primed probe combination and test kit
CN105624284A (en) Klebsiella pneumonia fluorescent PCR detection reagent kit
CN105624285A (en) Mycoplasma pneumoniae fluorescent PCR detection reagent kit
CN102634610A (en) Primer probe combination for specific detection of measles virus and rubella virus and kit
CN105624286A (en) Legionella pneumophila fluorescence PCR detection kit
CN102939378A (en) Compositions and methods for the rapid detection of legionella
CN103993090A (en) Specific nucleotides for providencia O31, O41, O42, O43 and O50 and application of specific nucleotides
CN101768633B (en) Composition for detecting O139 group vibrio cholerae, kit and detection method for food
CN109371150A (en) Pseudomonas aeruginosa fluorescence PCR detection reagent kit
CN102154279B (en) Detection method and specific SCAR (sequenced characterized amplified region) marker of tilletia controversa kuhn (TCK)
CN109439780A (en) Moraxelle catarrhalis fluorescence PCR detection reagent kit
KR20170030190A (en) Primers used for LAMP reaction for the detection of Clostridium perfringens and its use
CN103642901B (en) The specific detection of Neisseria meningitidis Z group primed probe combination and test kit
KR101299627B1 (en) Primers for simultaneous detection of foodborne bacteria and use thereof

Legal Events

Date Code Title Description
C06 Publication
DD01 Delivery of document by public notice

Addressee: Zhenjiang Hechuang Biotechnology Co.,Ltd.

Document name: Notification of Passing Preliminary Examination of the Application for Invention

Addressee: Zhenjiang Hechuang Biotechnology Co.,Ltd.

Document name: Notification to Make Rectification

PB01 Publication
C10 Entry into substantive examination
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: 212132 Jiangsu province Zhenjiang new Dingmao Road No. 668 by twelve

Applicant after: JIANGSU UNINOVO BIOLOGICAL TECHNOLOGY CO., LTD.

Address before: 212132 Jiangsu province Zhenjiang new Dingmao Road No. 668 by twelve

Applicant before: Zhenjiang Hechuang Biotechnology Co.,Ltd.

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: ZHENJIANG HECHUANG BIOTECHNOLOGY CO., LTD. TO: JIANGSU UNINOVO BIOLOGICAL TECHNOLOGY CO., LTD.

SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Primer probe combination and kit for specific detection of Streptococcus pneumoniae and Haemophilus influenzae

Effective date of registration: 20201015

Granted publication date: 20160928

Pledgee: Agricultural Bank of China Limited Zhenjiang Dantu sub branch

Pledgor: JIANGSU UNINOVO BIOLOGICAL TECHNOLOGY Co.,Ltd.

Registration number: Y2020980006837

PE01 Entry into force of the registration of the contract for pledge of patent right